vs
亚什兰（ASH）与MEDICAL PROPERTIES TRUST INC（MPW）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是MEDICAL PROPERTIES TRUST INC的1.4倍（$386.0M vs $270.3M），MEDICAL PROPERTIES TRUST INC净利率更高（6.5% vs -3.1%，领先9.6%），MEDICAL PROPERTIES TRUST INC同比增速更快（16.6% vs -4.7%），过去两年MEDICAL PROPERTIES TRUST INC的营收复合增速更高（-0.2% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
Medical Properties Trust, Inc.（MPT）是一家总部位于美国阿拉巴马州伯明翰的跨国房地产投资信托基金（REIT），主要在美欧地区收购、投资医疗保健设施与营利性医疗控股公司，资产收购多采用售后回租模式，原业主出售资产后成为其租户，租户通常需签署长期三净租赁协议。
ASH vs MPW — 直观对比
营收规模更大
ASH
是对方的1.4倍
$270.3M
营收增速更快
MPW
高出21.3%
-4.7%
净利率更高
MPW
高出9.6%
-3.1%
两年增速更快
MPW
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $270.3M |
| 净利润 | $-12.0M | $17.6M |
| 毛利率 | 27.2% | 95.8% |
| 营业利润率 | -1.6% | 9.7% |
| 净利率 | -3.1% | 6.5% |
| 营收同比 | -4.7% | 16.6% |
| 净利润同比 | 92.7% | 104.3% |
| 每股收益（稀释后） | $-0.26 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHMPW
| Q4 25 | $386.0M | $270.3M | ||
| Q3 25 | $477.0M | $237.5M | ||
| Q2 25 | $463.0M | $240.4M | ||
| Q1 25 | $479.0M | $223.8M | ||
| Q4 24 | $405.0M | $231.8M | ||
| Q3 24 | $521.0M | $225.8M | ||
| Q2 24 | $544.0M | $266.6M | ||
| Q1 24 | $575.0M | $271.3M |
净利润ASHMPW
| Q4 25 | $-12.0M | $17.6M | ||
| Q3 25 | $31.0M | $-77.7M | ||
| Q2 25 | $-742.0M | $-98.4M | ||
| Q1 25 | $31.0M | $-118.3M | ||
| Q4 24 | $-165.0M | $-412.3M | ||
| Q3 24 | $17.0M | $-801.2M | ||
| Q2 24 | $6.0M | $-320.6M | ||
| Q1 24 | $120.0M | $-875.6M |
毛利率ASHMPW
| Q4 25 | 27.2% | 95.8% | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | 91.8% | ||
| Q1 25 | 30.7% | 63.6% | ||
| Q4 24 | 27.4% | 90.9% | ||
| Q3 24 | 33.2% | 96.5% | ||
| Q2 24 | 34.2% | 98.4% | ||
| Q1 24 | 28.0% | 84.9% |
营业利润率ASHMPW
| Q4 25 | -1.6% | 9.7% | ||
| Q3 25 | 12.8% | -28.0% | ||
| Q2 25 | -152.9% | -36.7% | ||
| Q1 25 | 10.6% | -48.5% | ||
| Q4 24 | -44.2% | -173.7% | ||
| Q3 24 | 6.1% | -350.7% | ||
| Q2 24 | -11.2% | -114.5% | ||
| Q1 24 | 3.7% | -318.6% |
净利率ASHMPW
| Q4 25 | -3.1% | 6.5% | ||
| Q3 25 | 6.5% | -32.7% | ||
| Q2 25 | -160.3% | -40.9% | ||
| Q1 25 | 6.5% | -52.8% | ||
| Q4 24 | -40.7% | -177.8% | ||
| Q3 24 | 3.3% | -354.8% | ||
| Q2 24 | 1.1% | -120.3% | ||
| Q1 24 | 20.9% | -322.7% |
每股收益（稀释后）ASHMPW
| Q4 25 | $-0.26 | $0.03 | ||
| Q3 25 | $0.83 | $-0.13 | ||
| Q2 25 | $-16.21 | $-0.16 | ||
| Q1 25 | $0.65 | $-0.20 | ||
| Q4 24 | $-3.50 | $-0.68 | ||
| Q3 24 | $0.34 | $-1.34 | ||
| Q2 24 | $0.12 | $-0.54 | ||
| Q1 24 | $2.39 | $-1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $540.9M |
| 总债务越低越好 | $1.4B | $9.7B |
| 股东权益账面价值 | $1.9B | $4.6B |
| 总资产 | $4.5B | $15.0B |
| 负债/权益比越低杠杆越低 | 0.74× | 2.11× |
8季度趋势，按日历期对齐
现金及短期投资ASHMPW
| Q4 25 | $304.0M | $540.9M | ||
| Q3 25 | $215.0M | $396.6M | ||
| Q2 25 | $207.0M | $509.8M | ||
| Q1 25 | $168.0M | $673.5M | ||
| Q4 24 | $219.0M | $332.3M | ||
| Q3 24 | $300.0M | $275.6M | ||
| Q2 24 | $399.0M | $606.5M | ||
| Q1 24 | $439.0M | $224.3M |
总债务ASHMPW
| Q4 25 | $1.4B | $9.7B | ||
| Q3 25 | $1.4B | $9.6B | ||
| Q2 25 | $1.4B | $9.6B | ||
| Q1 25 | $1.3B | $9.5B | ||
| Q4 24 | $1.3B | $8.8B | ||
| Q3 24 | $1.3B | $9.2B | ||
| Q2 24 | $1.3B | $9.4B | ||
| Q1 24 | $1.3B | $10.1B |
股东权益ASHMPW
| Q4 25 | $1.9B | $4.6B | ||
| Q3 25 | $1.9B | $4.7B | ||
| Q2 25 | $1.9B | $4.8B | ||
| Q1 25 | $2.6B | $4.8B | ||
| Q4 24 | $2.6B | $4.8B | ||
| Q3 24 | $2.9B | $5.4B | ||
| Q2 24 | $3.0B | $6.2B | ||
| Q1 24 | $3.1B | $6.7B |
总资产ASHMPW
| Q4 25 | $4.5B | $15.0B | ||
| Q3 25 | $4.6B | $14.9B | ||
| Q2 25 | $4.6B | $15.2B | ||
| Q1 25 | $5.2B | $14.9B | ||
| Q4 24 | $5.2B | $14.3B | ||
| Q3 24 | $5.6B | $15.2B | ||
| Q2 24 | $5.7B | $16.2B | ||
| Q1 24 | $5.9B | $17.3B |
负债/权益比ASHMPW
| Q4 25 | 0.74× | 2.11× | ||
| Q3 25 | 0.73× | 2.06× | ||
| Q2 25 | 0.73× | 2.00× | ||
| Q1 25 | 0.52× | 1.99× | ||
| Q4 24 | 0.51× | 1.83× | ||
| Q3 24 | 0.47× | 1.69× | ||
| Q2 24 | 0.45× | 1.51× | ||
| Q1 24 | 0.42× | 1.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $230.8M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | 13.11× |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHMPW
| Q4 25 | $125.0M | $230.8M | ||
| Q3 25 | $40.0M | $18.6M | ||
| Q2 25 | $115.0M | $51.7M | ||
| Q1 25 | $9.0M | $384.0K | ||
| Q4 24 | $-30.0M | $245.5M | ||
| Q3 24 | $80.0M | $59.2M | ||
| Q2 24 | $127.0M | $35.3M | ||
| Q1 24 | $54.0M | $74.3M |
自由现金流ASHMPW
| Q4 25 | $111.0M | — | ||
| Q3 25 | $6.0M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $-12.0M | — | ||
| Q4 24 | $-53.0M | — | ||
| Q3 24 | $42.0M | — | ||
| Q2 24 | $98.0M | — | ||
| Q1 24 | $20.0M | — |
自由现金流率ASHMPW
| Q4 25 | 28.8% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 20.5% | — | ||
| Q1 25 | -2.5% | — | ||
| Q4 24 | -13.1% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 18.0% | — | ||
| Q1 24 | 3.5% | — |
资本支出强度ASHMPW
| Q4 25 | 3.6% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 5.9% | — |
现金转化率ASHMPW
| Q4 25 | — | 13.11× | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | — | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
MPW
暂无分部数据
